Disc Medicine
IRON
61.18
-0.47
-0.76%
Disc Medicine
US · IRON
#2647 by market cap
Listed 1970
61.18
-0.47
-0.76%
Live - 5344 symbols - heartbeat 296s ago
· 2026-10-08 07:13
Pre-market
60.70
-0.78%
After-hours
61.12
-0.10%
- Market cap
- 2.35B
- P/E (TTM)i
- -9.28
- P/Bi
- 3.65
- EPSi
- -6.01
- Div yieldi
- 0.00%
- 52W posi
- 36%
Reader sentiment
Are you bullish or bearish on IRON?
Anonymous reader poll. Unscientific, not investment advice.
Analyst consensus 11 analysts
Buy
Avg price target
102.22 +67.1%
Price target rangecurrent 61.18
Low86.00
Avg102.22
High125.00
Buy 100%
Hold 0%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-09-21 | Truist Financial | -- | BUY | -- |
| 2026-09-21 | H.C. Wainwright | -- | BUY | 120.00 |
| 2026-09-16 | Wells Fargo | -- | BUY | 86.00 |
| 2026-09-11 | Truist Financial | -- | BUY | -- |
| 2026-09-10 | LifeSci Capital | -- | BUY | 100.00 |
| 2026-09-10 | BMO Capital | -- | BUY | 100.00 |
| 2026-09-10 | Leerink Partners | -- | BUY | 100.00 |
| 2026-09-10 | H.C. Wainwright | -- | BUY | 120.00 |
| 2026-08-31 | Cantor Fitzgerald | -- | BUY | 125.00 |
| 2026-08-27 | LifeSci Capital | -- | BUY | 100.00 |
| 2026-08-17 | Morgan Stanley | -- | BUY | 90.00 |
| 2026-08-11 | Truist Financial | -- | BUY | -- |
| 2026-08-11 | Wedbush | -- | BUY | 88.00 |
| 2026-08-10 | H.C. Wainwright | -- | BUY | 120.00 |
| 2026-08-06 | H.C. Wainwright | -- | BUY | 120.00 |
| 2026-07-31 | Truist Financial | -- | BUY | 83.00 |
| 2026-07-31 | Wedbush | -- | BUY | 88.00 |
| 2026-07-31 | Stifel | -- | BUY | 111.00 |
| 2026-07-30 | TD Cowen | -- | BUY | -- |
| 2026-07-30 | LifeSci Capital | -- | BUY | 100.00 |
| 2026-06-16 | Truist Financial | -- | BUY | -- |
| 2026-06-16 | Wedbush | -- | BUY | 88.00 |
| 2026-06-16 | Morgan Stanley | -- | BUY | 85.00 |
| 2026-06-15 | LifeSci Capital | -- | BUY | 100.00 |
| 2026-06-15 | Morgan Stanley | -- | BUY | 85.00 |
Quant vs Street three independent views, side by side
StockVane factor grade
C
Momentum strategy signal
Sell
Analyst consensus
Buy
Signals diverge - worth digging into why.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Price target trend monthly average, last 3 years
Quote time 2026-10-08 07:13:37 · For reference only, not investment advice and not tailored to your situation.